Home Supplements How We Rate Blog
Crocus sativus

Saffron Extract

Research reviewed: Up until 03/2026

Saffron Extract (Crocus sativus) is a dietary supplement with 12 published peer-reviewed studies involving 870 participants, researched for Mood & Depression, Anxiety Relief, Cognitive Function.

12
Studies
870
Participants
2005–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Mood & Depression

Strong
5 studies 4 of 5 positive 260 participants

Anxiety Relief

Strong
3 studies 3 of 3 positive 251 participants

Cognitive Function

Strong
4 studies 4 of 4 positive 184 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

12/12
Randomised
11/12
Double-Blind
11/12
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2005)
40
Study 2 (2025)
128
Study 3 (2015)
0
Study 4 (2019)
52
Study 5 (2005)
40
Study 6 (2016)
128
Study 7 (2020)
68
Study 8 (2021)
55

Research Timeline

When the studies were published

2
2005
1
2008
2
2010
1
2015
1
2016
1
2019
1
2020
2
2021
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Mood & Depression

1

To assess the effects of Crocus sativus (saffron) in the treatment of mild to moderate depression

2005 40 participants 6 weeks 30 mg/day saffron extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the effects of Crocus sativus (saffron) in the treatment of mild to moderate depression

Dose

30 mg/day saffron extract

Participants

40 patients with mild to moderate depression

Duration

6 weeks

Results

Saffron produced significantly better outcome on HDRS than placebo (F=18.89, p<0.001) at 6 weeks.

How They Measured It

Hamilton Depression Rating Scale (HDRS)

Read full study
2

To assess the effects of saffron extract (Affron) on mood and well-being in adults experiencing low mood

2025 128 participants 8 weeks 28 mg/day Affron saffron extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the effects of saffron extract (Affron) on mood and well-being in adults experiencing low mood

Dose

28 mg/day Affron saffron extract

Participants

128 adults experiencing low mood

Duration

8 weeks

Results

Saffron extract significantly improved mood, positive affect, and reduced psychological distress vs placebo.

How They Measured It

Kessler-10 (K10), Profile of Mood States (POMS), positive affect

Read full study
3

To systematically evaluate the effects of saffron on depressive symptoms vs placebo and antidepressants

2015 ? participants Various Various
Human Study RCT Positive

Study Type

Meta-analysis of randomised clinical trials

Purpose

To systematically evaluate the effects of saffron on depressive symptoms vs placebo and antidepressants

Dose

Various

Participants

Multiple RCTs pooled

Duration

Various

Results

Saffron supplementation was significantly more effective than placebo and comparable to antidepressants for MDD.

How They Measured It

HDRS, MADRS, Beck Depression Inventory

Read full study
4

To assess Crocus sativus on depression and food craving among overweight women with mild to moderate depression

2019 52 participants 8 weeks 30 mg/day saffron extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess Crocus sativus on depression and food craving among overweight women with mild to moderate depression

Dose

30 mg/day saffron extract

Participants

52 overweight women with mild-moderate depression

Duration

8 weeks

Results

Mean depression scores significantly decreased in saffron group vs placebo (-8.4 vs -3.9, p=0.007).

How They Measured It

HDRS, food craving questionnaire, body weight

Read full study
5

To compare saffron with fluoxetine in the treatment of mild to moderate depression

2005 40 participants 8 weeks 30 mg/day saffron extract
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To compare saffron with fluoxetine in the treatment of mild to moderate depression

Dose

30 mg/day saffron extract

Participants

40 depressed patients

Duration

8 weeks

Results

Saffron was as effective as fluoxetine in reducing depression scores, with comparable safety profile.

How They Measured It

HDRS, Beck Depression Inventory (BDI)

Read full study

Anxiety Relief

6

To assess the effects of saffron extract for the treatment of anxiety and depression

2016 128 participants 12 weeks 14 mg twice daily saffron extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the effects of saffron extract for the treatment of anxiety and depression

Dose

14 mg twice daily saffron extract

Participants

128 adults with anxiety and depression

Duration

12 weeks

Results

Saffron extract significantly improved anxiety scores (HADS-A) and depression vs placebo (p<0.05).

How They Measured It

Hospital Anxiety and Depression Scale (HADS), DASS-21

Read full study
7

To assess saffron for anxiety in adolescents with mild anxiety and depressive symptoms

2020 68 participants 8 weeks 14 mg twice daily
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess saffron for anxiety in adolescents with mild anxiety and depressive symptoms

Dose

14 mg twice daily

Participants

68 adolescents (12-16 years)

Duration

8 weeks

Results

Saffron supplementation significantly reduced anxiety scores in adolescents vs placebo (p<0.05).

How They Measured It

SCARED anxiety scale, Child Depression Rating Scale

Read full study
8

To evaluate saffron supplementation on anxiety and sleep in adults

2021 55 participants 8 weeks 28 mg/day saffron
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate saffron supplementation on anxiety and sleep in adults

Dose

28 mg/day saffron

Participants

55 adults with mild anxiety

Duration

8 weeks

Results

Saffron significantly reduced anxiety scores and improved sleep quality vs placebo; lower salivary cortisol.

How They Measured It

GAD-7, Insomnia Severity Index, cortisol

Read full study

Cognitive Function

9

To evaluate saffron supplementation on cognitive function in patients with Alzheimer's disease

2010 46 participants 16 weeks 30 mg/day saffron extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate saffron supplementation on cognitive function in patients with Alzheimer's disease

Dose

30 mg/day saffron extract

Participants

46 Alzheimer's disease patients

Duration

16 weeks

Results

Saffron supplementation significantly improved ADAS-cog scores comparable to donepezil, with better safety profile.

How They Measured It

ADAS-cog, MMSE

Read full study
10

To assess saffron effect on age-related macular degeneration and visual function

2010 25 participants 3 months 20 mg/day saffron
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess saffron effect on age-related macular degeneration and visual function

Dose

20 mg/day saffron

Participants

25 AMD patients

Duration

3 months

Results

Saffron supplementation significantly improved retinal function (flicker sensitivity) in early AMD patients.

How They Measured It

Visual acuity, retinal sensitivity, flicker sensitivity

Read full study
11

To evaluate saffron supplementation on subjective sleep quality

2021 63 participants 28 days 14 mg twice daily saffron
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate saffron supplementation on subjective sleep quality

Dose

14 mg twice daily saffron

Participants

63 adults with insomnia

Duration

28 days

Results

Saffron significantly improved PSQI total score and sleep efficiency vs placebo.

How They Measured It

Pittsburgh Sleep Quality Index (PSQI), actigraphy

Read full study
12

To evaluate saffron effects on premenstrual syndrome (PMS) symptoms

2008 50 participants 2 menstrual cycles 30 mg/day saffron capsules
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate saffron effects on premenstrual syndrome (PMS) symptoms

Dose

30 mg/day saffron capsules

Participants

50 women with PMS

Duration

2 menstrual cycles

Results

Saffron significantly reduced PMS symptoms including mood symptoms, irritability, and anxiety vs placebo.

How They Measured It

DRSP (Daily Record of Severity of Problems)

Read full study

Frequently Asked Questions

Common questions about Saffron Extract research

What does the research say about Saffron Extract?

There are currently 12 peer-reviewed studies on Saffron Extract (Crocus sativus), involving 870 total participants. Research covers Mood & depression, Anxiety relief, Cognitive function. The overall evidence strength is rated as Very Strong.

How strong is the evidence for Saffron Extract?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (12 human studies), and reported outcomes.

What health goals has Saffron Extract been studied for?

Saffron Extract has been researched for: Mood & depression, Anxiety relief, Cognitive function. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Saffron Extract based on human trials?

Yes, 12 out of 12 studies are human trials. Human trials carry more weight in our evidence scoring system.